Tranylcypromine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg
Reference Brands: Parnate® (US & EU)
Category:
Antipsychotropic Drugs
Tranylcypromine is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) that increases the levels of norepinephrine, serotonin, and dopamine in the brain by inhibiting their breakdown. This enhances mood and cognitive function. It is primarily used to treat major depressive disorder (MDD) in patients unresponsive to other antidepressants. Due to its MAOI activity, it requires strict dietary restrictions and careful drug interaction monitoring to avoid hypertensive crises.
Tranylcypromine Tablets is available in Tablets
and strengths such as 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tranylcypromine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tranylcypromine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tranylcypromine, marketed under the well-known brand Parnate®, is a classic monoamine oxidase inhibitor (MAOI) used to treat major depressive disorder (MDD), especially in cases unresponsive to conventional antidepressants. Available as 10 mg oral tablets in both the US and EU, Tranylcypromine works by irreversibly inhibiting the MAO enzyme, increasing brain levels of serotonin, norepinephrine, and dopamine. Although dietary restrictions apply, it remains a vital option in psychiatric practice for severe and atypical depression. Connect with certified Tranylcypromine manufacturers and suppliers at Pharmatradz.com, your global B2B pharmaceutical marketplace.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing